Antigen Provoking Gamma Interferon Production in Response to Mycobacterium Bovis BCG and Functional Difference in T-cell Responses to This Antigen Between Viable and Killed BCG-immunized Mice

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1994 Oct 1

PMID 7927701

Citations 4

Authors

I Kawamura

J Yang

Y Takaesu

M Fujita

K Nomoto

M Mitsuyama

Affiliations

Soon will be listed here.

Abstract

It has been shown that gamma interferon (IFN-gamma)-producing CD4+ T cells, which are generated only by immunization with viable bacteria, exert a significant role in protective immunity against mycobacteria in mice. In this study, we have tried to determine the antigen recognized by the T cells in search of a possible protective antigen. T cells from viable Mycobacterium bovis BCG-immunized mice were stimulated with several antigens, and IFN-gamma production was measured. Purified protein derivative and viable and killed BCG lysates caused significant IFN-gamma production, and almost the same level of IFN-gamma activity was detected in both groups stimulated with viable and killed BCG lysates. However, heat shock protein (HSP) 65 and HSP 70 were not a major antigen for IFN-gamma production. The antigen provoking IFN-gamma production is localized mainly in the membrane fraction of BCG cells, and the approximate molecular size was 18 kDa. On the other hand, T cells from killed BCG-immunized mice never responded to this antigen for IFN-gamma production, whereas they could mount a delayed-type hypersensitivity response. These results showed that the antigen provoking IFN-gamma production was present in killed as well as viable BCG. In addition to the antigen presentation by antigen-presenting cells, some kinds of differentiation factor (such as monokines) that are produced only by stimulation with viable cells seemed to be necessary for the development of IFN-gamma-producing T cells.

Citing Articles

Detection of prokaryotic mRNA signifies microbial viability and promotes immunity.

Sander L, Davis M, Boekschoten M, Amsen D, Dascher C, Ryffel B Nature. 2011; 474(7351):385-9.

PMID: 21602824 PMC: 3289942. DOI: 10.1038/nature10072.

Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice.

Shibata Y, Honda I, Justice J, Van Scott M, Nakamura R, Myrvik Q Infect Immun. 2001; 69(10):6123-30.

PMID: 11553551 PMC: 98742. DOI: 10.1128/IAI.69.10.6123-6130.2001.

An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice.

Yang J, Mitsuyama M Immunology. 1997; 91(4):529-35.

PMID: 9378490 PMC: 1363871. DOI: 10.1046/j.1365-2567.1997.00288.x.

Requirement of the initial production of gamma interferon in the generation of protective immunity of mice against Listeria monocytogenes.

Yang J, Kawamura I, Mitsuyama M Infect Immun. 1997; 65(1):72-7.

PMID: 8975894 PMC: 174558. DOI: 10.1128/iai.65.1.72-77.1997.

References

Tsukada H, Kawamura I, Arakawa M, Nomoto K, Mitsuyama M . Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect Immun. 1991; 59(10):3589-95. PMC: 258925. DOI: 10.1128/iai.59.10.3589-3595.1991. View

Kochi A . The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991; 72(1):1-6. DOI: 10.1016/0041-3879(91)90017-m. View

Singh I, Mukherjee R, Talwar G, Kaufmann S . In vitro characterization of T cells from Mycobacterium w-vaccinated mice. Infect Immun. 1992; 60(1):257-63. PMC: 257530. DOI: 10.1128/iai.60.1.257-263.1992. View

Walker K, Butler R, Colston M . Role of Th-1 lymphocytes in the development of protective immunity against Mycobacterium leprae. Analysis of lymphocyte function by polymerase chain reaction detection of cytokine messenger RNA. J Immunol. 1992; 148(6):1885-9. View

Young D, Kaufmann S, Hermans P, Thole J . Mycobacterial protein antigens: a compilation. Mol Microbiol. 1992; 6(2):133-45. DOI: 10.1111/j.1365-2958.1992.tb01994.x. View

Huygen K, Abramowicz D, Vandenbussche P, Jacobs F, de Bruyn J, Kentos A . Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun. 1992; 60(7):2880-6. PMC: 257249. DOI: 10.1128/iai.60.7.2880-2886.1992. View

Carlucci S, Beschin A, Tuosto L, Ameglio F, Gandolfo G, Cocito C . Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun. 1993; 61(2):439-47. PMC: 302748. DOI: 10.1128/iai.61.2.439-447.1993. View

Dalton D, Keshav S, Figari I, Bradley A, Stewart T . Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993; 259(5102):1739-42. DOI: 10.1126/science.8456300. View

Orme I, Andersen P, Boom W . T cell response to Mycobacterium tuberculosis. J Infect Dis. 1993; 167(6):1481-97. DOI: 10.1093/infdis/167.6.1481. View

10.

Barnes P, Lu S, Abrams J, Wang E, Yamamura M, Modlin R . Cytokine production at the site of disease in human tuberculosis. Infect Immun. 1993; 61(8):3482-9. PMC: 281026. DOI: 10.1128/iai.61.8.3482-3489.1993. View

11.

Ellner J, Hinman A, DOOLEY S, Fischl M, Sepkowitz K, Goldberger M . Tuberculosis symposium: emerging problems and promise. J Infect Dis. 1993; 168(3):537-51. DOI: 10.1093/infdis/168.3.537. View

12.

Snider Jr D . The tuberculin skin test. Am Rev Respir Dis. 1982; 125(3 Pt 2):108-18. DOI: 10.1164/arrd.1982.125.3P2.108. View

13.

Lovik M, Closs O . Repeated delayed-type hypersensitivity reactions against Mycobacterium lepraemurium antigens at the infection site do not affect bacillary multiplication in C3H mice. Infect Immun. 1982; 36(2):768-74. PMC: 351296. DOI: 10.1128/iai.36.2.768-774.1982. View

14.

Nathan C, Murray H, Wiebe M, Rubin B . Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983; 158(3):670-89. PMC: 2187114. DOI: 10.1084/jem.158.3.670. View

15.

Buchmeier N, Schreiber R . Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci U S A. 1985; 82(21):7404-8. PMC: 391353. DOI: 10.1073/pnas.82.21.7404. View

16.

Rook G, Steele J, Ainsworth M, Champion B . Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology. 1986; 59(3):333-8. PMC: 1453207. View

17.

Filley E, Steele J, Rook G . A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods. 1987; 98(1):5-10. DOI: 10.1016/0022-1759(87)90429-7. View

18.

Flesch I, Kaufmann S . Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol. 1987; 138(12):4408-13. View

19.

Muller I, Cobbold S, Waldmann H, Kaufmann S . Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun. 1987; 55(9):2037-41. PMC: 260652. DOI: 10.1128/iai.55.9.2037-2041.1987. View

20.

Pedrazzini T, Hug K, Louis J . Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo. J Immunol. 1987; 139(6):2032-7. View